ImmunityBio & BeiGene Launch Phase 3 Trial for ANKTIVA® and PD-1 Inhibitor in NSCLC
ImmunityBio, Inc. (NASDAQ: IBRX) has announced a strategic collaboration and supply agreement with BeiGene, Ltd. (soon to be renamed BeOne Medicines, Ltd.), a global oncology company. The partnership will focus…
Leveragen & Moonlight Bio Partner to Advance T Cell Therapies
Leveragen Inc. and Moonlight Bio Forge Strategic Collaboration to Revolutionize T Cell Therapies for Cancer Treatment Leveragen Inc., a pioneering biotech company based in Boston, has announced a groundbreaking partnership…
Scholar Rock Submits BLA to FDA for Apitegromab in SMA Treatment
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to developing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other severe conditions driven by protein growth factors, has…
Dr. Stephanie Simmons of Photonic Inc. to Headline UNESCO’s Quantum Science and Technology Launch Event
Photonic Inc. Founder Dr. Stephanie Simmons to Speak at UNESCO’s International Year of Quantum Science and Technology Opening Ceremony Paris, France – February 4-5, 2025 – Photonic Inc., a global…
Arizona ADHD Center Opens New Scottsdale Clinic 28.01.2025
Arizona ADHD Center Expands with New Scottsdale Clinic, Enhancing ADHD Diagnosis and Treatment Arizona ADHD Center, a premier medical and behavioral health clinic specializing in ADHD diagnosis, treatment, and ongoing…
Nanoemulsions Market Report 2024-2030: Analysis & Forecasts by Drug Class
Global Nanoemulsions Market Report 2024-2030: Growth Trends, Applications, and Forecasts Nanoemulsions – Global Strategic Business Report,” providing an in-depth analysis of the expanding nanoemulsions market. This report examines industry trends,…
JCR Pharmaceuticals to Showcase at the 21st Annual WORLDSymposium™ 2025
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025 in San Diego JCR Pharmaceuticals Co., Ltd. (TSE 4552), a leading global specialty pharmaceutical company, has announced its participation in…
Modella AI’s PathChat Co-Pilot Earns FDA Breakthrough Device Status
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, has announced that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the…
GeminiBio Appoints Matt Stober to Board of Directors
GeminiBio Appoints Matt Stober to Board of Directors Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of raw materials to the biopharmaceutical and advanced therapy industries, has announced the appointment of…
Trilobio Unveils Groundbreaking Whole-Laboratory Automation Platform at SLAS2025
Trilobio Unveils Revolutionary Whole-Lab Automation Platform at SLAS2025: A Game-Changer for Life Science Research San Diego, CA – January 25-29, 2025 – Trilobio, a pioneering developer of whole-laboratory automation solutions,…
Sage Therapeutics Rejects Biogen’s Acquisition Proposal, Explores Strategic Alternatives
Sage Therapeutics Explores Strategic Alternatives and Rejects Biogen’s Acquisition Offer Sage Therapeutics, Inc. (Nasdaq: SAGE), a leader in brain health therapeutics, announced today that its Board of Directors has initiated…
Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize 3D Cell Culture in Drug Discovery
Inventia Life Science Unveils RASTRUM™ Allegro to Transform 3D Cell Culture in Drug Discovery and Disease Research Inventia Life Science, a leader in 3D cell culture technologies, has announced the…